Raymond James & Associates’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Raymond James & Associates’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,601	Closed	-$22K	–	3160
2016 Q1	$22K	Buy	+10,601	New	+$18.9K	﹤0.01%	2851
2014 Q1	–	Sell	-28,840	Closed	-$314K	–	2175
2013 Q4	$314K	Buy	+28,840	New	+$284K	﹤0.01%	1836

Raymond James & Associates's SZYM Position: Q2 2016 in Review

Raymond James & Associates sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 10,601 shares — an estimated $22K sold.

Raymond James & Associates first reported a position in SZYM in Q4 2013 and held it in 2 quarters. The position peaked at $314K in Q4 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

Raymond James & Associates reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Raymond James & Associates sold 10,601 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $22K.
Raymond James & Associates first reported a position in SOLAZYME INC COM STK (DE) in Q4 2013 and held it in 2 quarters.
Raymond James & Associates's SOLAZYME INC COM STK (DE) position peaked at $314K in Q4 2013.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.